Literature DB >> 3024956

Gastroduodenal polyps in familial adenomatous and juvenile polyposis.

H J Järvinen, P Sipponen.   

Abstract

Upper gastrointestinal endoscopy revealed gastroduodenal polyps in 45 (90%) out of 50 patients with familial adenomatosis (FA), and in 11 (92%) out of 12 patients with juvenile polyposis (JP). The polyps in the fundic and corpus regions of the stomach were hamartomatous cystic body gland polyps in 28 (56%), and adenomas in 3 (6%) of the FA patients, while 6 (50%) JP patients had hyperplastic polyps in the corresponding region. The polyps in the gastric antrum and duodenum were adenomas in 6 (12%) and 25 (50%) of the FA patients, respectively, while the polyps of the corresponding regions were hyperplastic in 10 (83%) and 2 (17%) of the JP subjects. One focal adenomatous lesion in an antral hyperplastic polyp, and one duodenal adenoma were found in the JP patients. Furthermore, one duodenal adenocarcinoma was observed among the FA subjects. It is concluded that gastroduodenal polyps belong inherently both to adenomatous and to juvenile varieties of gastrointestinal polyposis, and that these two conditions have characteristic histological patterns and topography of polyps in the upper gastrointestinal tract.

Entities:  

Mesh:

Year:  1986        PMID: 3024956     DOI: 10.1055/s-2007-1018386

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  17 in total

1.  Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation.

Authors:  Changqing Ma; Francis M Giardiello; Elizabeth A Montgomery
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

2.  Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis.

Authors:  H F Vasen; S Bülow; T Myrhøj; L Mathus-Vliegen; G Griffioen; E Buskens; B G Taal; F Nagengast; J F Slors; P de Ruiter
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

3.  Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene.

Authors:  S C Abraham; B Nobukawa; F M Giardiello; S R Hamilton; T T Wu
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Surgical aspects of familial adenomatous polyposis.

Authors:  T Berk; S Bülow; Z Cohen; J J DeCosse; P R Hawley; D G Jagelman; H J Järvinen; F A Macrae
Journal:  Int J Colorectal Dis       Date:  1988-03       Impact factor: 2.571

5.  Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations.

Authors:  S C Abraham; B Nobukawa; F M Giardiello; S R Hamilton; T T Wu
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.

Authors:  P Domizio; I C Talbot; A D Spigelman; C B Williams; R K Phillips
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

7.  Diagnosis of familial adenomatous polyposis.

Authors:  S Bülow
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

8.  Gross and histological abnormalities of the foregut in familial adenomatous polyposis: a study from a South East Asian Registry.

Authors:  F Seow-Choen; J M Ho; J Wong; H S Goh
Journal:  Int J Colorectal Dis       Date:  1992-12       Impact factor: 2.571

9.  Colorectal neoplasia in juvenile polyposis or juvenile polyps.

Authors:  F M Giardiello; S R Hamilton; S E Kern; G J Offerhaus; P A Green; P Celano; A J Krush; S V Booker
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

10.  Prophylactic total gastrectomy in the management of hereditary tumor syndromes.

Authors:  Dimitrios Pantelis; Robert Hüneburg; Ronja Adam; Stefanie Holzapfel; Heidrun Gevensleben; Jacob Nattermann; Christian P Strassburg; Stefan Aretz; Jörg C Kalff
Journal:  Int J Colorectal Dis       Date:  2016-09-28       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.